Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults

por Dos Santos, Reinaldo S., Guzman-Llorens, Daniel, Perez-Serna, Atenea A., Nadal, Angel, Marroqui, Laura
Publicado 2023

BCL-XL Overexpression Protects Pancreatic β-Cells against Cytokine- and Palmitate-Induced Apoptosis

por Perez-Serna, Atenea A., Dos Santos, Reinaldo S., Ripoll, Cristina, Nadal, Angel, Eizirik, Decio L., Marroqui, Laura
Publicado 2023